arrow
D

Daria V. Vasina

ministry of health of the russian federation
H指数:21
被引数:1,209

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Activity and Biocompatibility Evaluation of Enzybiotic Compositions Formulated with Azotobacter vinelandii Alginate for Topical Use

含维涅兰德固氮菌 alginate 的酶菌素制剂的活性和生物相容性评价用于局部使用

2026-04-270
OAAI
Novel Multistage Subunit Mycobacterium tuberculosis Nanoparticle Vaccine Confers Protection Against Experimental Infection in Prophylactic and Therapeutic Regimens

新型多阶段亚单位结核分枝杆菌纳米粒疫苗在预防和治疗方案中均能提供实验性感染保护

2025-12-191
OA
Wound-Healing Potential of Engineered Lysin GRC-ML07 in Pseudomonas aeruginosa Infected Wounds in Immunocompromised Mice

工程化溶素GRC-ML07在免疫抑制小鼠铜绿假单胞菌感染伤口中的伤口愈合潜力

2025-12-100
OA
Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections
2024-07-241
OAAI
Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus
2022-11-166
OAAI
Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance

Sputnik V在Omicron统治期间对新型冠状病毒肺炎住院的有效性

2022-06-1313
OAAI
Discovering the Potentials of Four Phage Endolysins to Combat Gram-Negative Infections

发现四种噬菌体内溶素对抗革兰氏阴性感染的潜力

2021-10-1335
OAAI
Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation
2021-05-1077
OAAI
Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study

重组亚单位结核疫苗候选物GamTBvac的安全性和免疫原性: 一项II期,多中心,双盲,随机,安慰剂对照研究

2020-11-0344
OAAI